Literature DB >> 28034992

Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone.

Maria Rosa Lidonnici1,2, Annamaria Aprile1,3, Marta Claudia Frittoli4, Giacomo Mandelli1, Ylenia Paleari1,2, Antonello Spinelli5, Bernhard Gentner4, Matilde Zambelli6, Cristina Parisi6, Laura Bellio6, Elena Cassinerio7, Laura Zanaboni7, Maria Domenica Cappellini7, Fabio Ciceri4, Sarah Marktel4, Giuliana Ferrari8,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28034992      PMCID： PMC5395121          DOI： 10.3324/haematol.2016.154740

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis.

Authors:  Koichi Akashi; Xi He; Jie Chen; Hiromi Iwasaki; Chao Niu; Brooke Steenhard; Jiwang Zhang; Jeff Haug; Linheng Li
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

Review 2.  The bicyclam AMD3100 story.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

3.  AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.

Authors:  André Larochelle; Allen Krouse; Mark Metzger; Donald Orlic; Robert E Donahue; Simon Fricker; Gary Bridger; Cynthia E Dunbar; Peiman Hematti
Journal:  Blood       Date:  2006-01-26       Impact factor: 22.113

4.  Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures.

Authors:  Robert E Donahue; Ping Jin; Aylin C Bonifacino; Mark E Metzger; Jiaqiang Ren; Ena Wang; David F Stroncek
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

5.  Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment.

Authors:  Faiyaz Notta; Sergei Doulatov; Elisa Laurenti; Armando Poeppl; Igor Jurisica; John E Dick
Journal:  Science       Date:  2011-07-08       Impact factor: 47.728

6.  Mild Heat Treatment Primes Human CD34(+) Cord Blood Cells for Migration Toward SDF-1α and Enhances Engraftment in an NSG Mouse Model.

Authors:  Maegan L Capitano; Giao Hangoc; Scott Cooper; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

7.  Hematopoietic stem cell mobilization for gene therapy: superior mobilization by the combination of granulocyte-colony stimulating factor plus plerixafor in patients with β-thalassemia major.

Authors:  Evangelia Yannaki; Garyfalia Karponi; Fani Zervou; Varnavas Constantinou; Asimina Bouinta; Varvara Tachynopoulou; Konstantina Kotta; Erica Jonlin; Thalia Papayannopoulou; Achilles Anagnostopoulos; George Stamatoyannopoulos
Journal:  Hum Gene Ther       Date:  2013-10       Impact factor: 5.695

8.  Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.

Authors:  David A Hess; Jesper Bonde; Timothy P Craft; Timothy C Craft; Louisa Wirthlin; Sarah Hohm; Ryan Lahey; Laura M Todt; John F Dipersio; Steven M Devine; Jan A Nolta
Journal:  Biol Blood Marrow Transplant       Date:  2007-04       Impact factor: 5.742

9.  Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.

Authors:  Hal E Broxmeyer; Christie M Orschell; D Wade Clapp; Giao Hangoc; Scott Cooper; P Artur Plett; W Conrad Liles; Xiaxin Li; Barbara Graham-Evans; Timothy B Campbell; Gary Calandra; Gary Bridger; David C Dale; Edward F Srour
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307

10.  Transcriptome analysis identifies regulators of hematopoietic stem and progenitor cells.

Authors:  Roi Gazit; Brian S Garrison; Tata Nageswara Rao; Tal Shay; James Costello; Jeff Ericson; Francis Kim; James J Collins; Aviv Regev; Amy J Wagers; Derrick J Rossi
Journal:  Stem Cell Reports       Date:  2013-08-15       Impact factor: 7.765
View more
  11 in total

Review 1.  Gene therapy using haematopoietic stem and progenitor cells.

Authors:  Giuliana Ferrari; Adrian J Thrasher; Alessandro Aiuti
Journal:  Nat Rev Genet       Date:  2020-12-10       Impact factor: 53.242

Review 2.  New therapeutic targets in transfusion-dependent and -independent thalassemia.

Authors:  M Domenica Cappellini; Irene Motta
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 3.  Gene Therapy for β-Hemoglobinopathies.

Authors:  Marina Cavazzana; Chiara Antoniani; Annarita Miccio
Journal:  Mol Ther       Date:  2017-04-01       Impact factor: 11.454

4.  Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.

Authors:  Giulia Pavani; Anna Fabiano; Marine Laurent; Fatima Amor; Erika Cantelli; Anne Chalumeau; Giulia Maule; Alexandra Tachtsidi; Jean-Paul Concordet; Anna Cereseto; Fulvio Mavilio; Giuliana Ferrari; Annarita Miccio; Mario Amendola
Journal:  Blood Adv       Date:  2021-03-09

5.  Collection and Processing of Mobilized Mouse Peripheral Blood at Lowered Oxygen Tension Yields Enhanced Numbers of Hematopoietic Stem Cells.

Authors:  Arafat Aljoufi; Scott Cooper; Hal E Broxmeyer
Journal:  Stem Cell Rev Rep       Date:  2020-10       Impact factor: 5.739

6.  Evidence for continued dose escalation of plerixafor for hematopoietic progenitor cell collections in sickle cell disease.

Authors:  Farid Boulad; Jiahao Zhang; Karina Yazdanbakhsh; Michel Sadelain; Patricia A Shi
Journal:  Blood Cells Mol Dis       Date:  2021-06-15       Impact factor: 2.372

7.  Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy.

Authors:  Erika Zonari; Giacomo Desantis; Carolina Petrillo; Francesco E Boccalatte; Maria Rosa Lidonnici; Anna Kajaste-Rudnitski; Alessandro Aiuti; Giuliana Ferrari; Luigi Naldini; Bernhard Gentner
Journal:  Stem Cell Reports       Date:  2017-03-16       Impact factor: 7.765

Review 8.  Curing Hemoglobinopathies: Challenges and Advances of Conventional and New Gene Therapy Approaches.

Authors:  Irene Motta; Valentina Ghiaccio; Andrea Cosentino; Laura Breda
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-11-01       Impact factor: 2.576

Review 9.  Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.

Authors:  Ajaz A Bhat; Sabah Nisar; Selma Maacha; Tatiana Correa Carneiro-Lobo; Sabah Akhtar; Kodappully Sivaraman Siveen; Nissar A Wani; Arshi Rizwan; Puneet Bagga; Mayank Singh; Ravinder Reddy; Shahab Uddin; Jean-Charles Grivel; Gyan Chand; Michael P Frenneaux; Mushtaq A Siddiqi; Davide Bedognetti; Wael El-Rifai; Muzafar A Macha; Mohammad Haris
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

Review 10.  Gene Therapy for Hemoglobinopathies.

Authors:  Marina Cavazzana; Fulvio Mavilio
Journal:  Hum Gene Ther       Date:  2018-10       Impact factor: 5.695
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.